Walden Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Walden Biosciences's estimated annual revenue is currently $2.5M per year.
- Walden Biosciences's estimated revenue per employee is $77,500
- Walden Biosciences's total funding is $51M.
Employee Data
- Walden Biosciences has 32 Employees.
- Walden Biosciences grew their employee count by -6% last year.
Walden Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Head BioTherapeutics | Reveal Email/Phone |
2 | Manager, Executive Office President & CEO | Reveal Email/Phone |
Walden Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Walden Biosciences?
Walden Biosciences is a biotechnology company relentlessly focused on developing first-in-class, highly-targeted therapies for individuals living with kidney disease. We are developing breakthrough medicines targeted directly to the kidney and will be successful through our comprehensive knowledge and understanding of novel kidney-specific biological pathways and our team's track record in drug discovery. Our goal is to transform the treatment of kidney disease by reversing its progression, enabling and inspiring patients to resume their normal lives. Our culture is collaborative and entrepreneurial, and our team is dynamic and driven by data and innovation. We want to make the best decisions with the best available information, lead by example, and bring transformative medicines to patients in need. Walden is based in the heart of Cambridge, MA between Harvard, Massachusetts Institute of Technology (MIT), and Massachusetts General Hospital.
keywords:N/A$51M
Total Funding
32
Number of Employees
$2.5M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Walden Biosciences News
Walden Biosciences Announces Presentation at the 32nd Annual Oppenheimer Healthcare Conference. March 11, 2022 07:00 ET | Source: Walden Biosciences,...
CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 32 | -9% | N/A |
#2 | $3.5M | 32 | 23% | $85.2M |
#3 | $3.7M | 32 | N/A | N/A |
#4 | $3.6M | 32 | 19% | N/A |
#5 | $6.9M | 32 | 23% | N/A |